Pie Medical Imaging

Pie Medical Imaging is a commercial-stage, private medical device software company focused on cardiovascular image analysis. Its core technology platform, CAAS (Cardiovascular Angiographic Analysis Systems), provides a suite of software modules for quantitative analysis, including its flagship vFFR (virtual Fractional Flow Reserve) product for non-invasive coronary pressure assessment. The company, a part of the Esaote group since 1998, targets the growing market for procedural planning and quantitative diagnostics in interventional cardiology and structural heart disease. Its products are regulatory cleared (CE Mark, FDA 510(k)) and supported by clinical validation, such as the recent FAST III trial demonstrating non-inferiority of its vFFR to invasive wire-based FFR.

CAAS (Cardiovascular Angiographic Analysis Systems) platform: A suite of software modules for 3D reconstruction, quantitative analysis, and computational modeling of cardiovascular images from angiography, CT, MRI, and echocardiography. Core technologies include vFFR (virtual Fractional Flow Reserve) and advanced 3D visualization.

PMI competes in a crowded market against large, integrated imaging companies (Philips, Siemens, GE) offering bundled solutions, and against specialized software and AI firms focusing on cardiovascular analysis (e.g., Circle Cardiovascular Imaging, Cleerly, Ultromics). Its differentiation lies in its deep, modality-specific quantitative analysis heritage, strong clinical validation (e.g., FAST III), and a focused portfolio on cardiology.